nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—ABCG2—primary biliary cirrhosis	0.383	1	CbGaD
Dasatinib—SRMS—gall bladder—primary biliary cirrhosis	0.0061	0.0613	CbGeAlD
Dasatinib—BMX—epithelium—primary biliary cirrhosis	0.0033	0.0332	CbGeAlD
Dasatinib—STAT5B—epithelium—primary biliary cirrhosis	0.00292	0.0294	CbGeAlD
Dasatinib—TEC—liver—primary biliary cirrhosis	0.00283	0.0285	CbGeAlD
Dasatinib—PDGFRA—gall bladder—primary biliary cirrhosis	0.0026	0.0261	CbGeAlD
Dasatinib—BMPR1B—epithelium—primary biliary cirrhosis	0.00234	0.0235	CbGeAlD
Dasatinib—EPHB1—liver—primary biliary cirrhosis	0.00222	0.0224	CbGeAlD
Dasatinib—KIT—gall bladder—primary biliary cirrhosis	0.00208	0.0209	CbGeAlD
Dasatinib—PDGFRB—gall bladder—primary biliary cirrhosis	0.00203	0.0204	CbGeAlD
Dasatinib—SIK2—liver—primary biliary cirrhosis	0.00197	0.0198	CbGeAlD
Dasatinib—FRK—liver—primary biliary cirrhosis	0.00191	0.0193	CbGeAlD
Dasatinib—CSK—smooth muscle tissue—primary biliary cirrhosis	0.00191	0.0192	CbGeAlD
Dasatinib—RIPK2—epithelium—primary biliary cirrhosis	0.00184	0.0185	CbGeAlD
Dasatinib—ERBB3—epithelium—primary biliary cirrhosis	0.00176	0.0177	CbGeAlD
Dasatinib—STAT5B—liver—primary biliary cirrhosis	0.00166	0.0166	CbGeAlD
Dasatinib—MAPK14—epithelium—primary biliary cirrhosis	0.00164	0.0165	CbGeAlD
Dasatinib—MAPK14—smooth muscle tissue—primary biliary cirrhosis	0.00158	0.0159	CbGeAlD
Dasatinib—EPHB4—epithelium—primary biliary cirrhosis	0.00155	0.0156	CbGeAlD
Dasatinib—JAK2—epithelium—primary biliary cirrhosis	0.00154	0.0155	CbGeAlD
Dasatinib—EPHA2—epithelium—primary biliary cirrhosis	0.00152	0.0153	CbGeAlD
Dasatinib—EPHB4—smooth muscle tissue—primary biliary cirrhosis	0.00149	0.015	CbGeAlD
Dasatinib—SIK3—liver—primary biliary cirrhosis	0.00149	0.015	CbGeAlD
Dasatinib—JAK2—smooth muscle tissue—primary biliary cirrhosis	0.00148	0.0149	CbGeAlD
Dasatinib—FYN—smooth muscle tissue—primary biliary cirrhosis	0.00146	0.0147	CbGeAlD
Dasatinib—MAP4K5—smooth muscle tissue—primary biliary cirrhosis	0.00143	0.0144	CbGeAlD
Dasatinib—ZAK—liver—primary biliary cirrhosis	0.00138	0.0139	CbGeAlD
Dasatinib—LYN—liver—primary biliary cirrhosis	0.00135	0.0135	CbGeAlD
Dasatinib—YES1—smooth muscle tissue—primary biliary cirrhosis	0.00132	0.0133	CbGeAlD
Dasatinib—BTK—liver—primary biliary cirrhosis	0.00132	0.0133	CbGeAlD
Dasatinib—SRC—epithelium—primary biliary cirrhosis	0.00132	0.0133	CbGeAlD
Dasatinib—TNK2—liver—primary biliary cirrhosis	0.0013	0.0131	CbGeAlD
Dasatinib—PDGFRA—smooth muscle tissue—primary biliary cirrhosis	0.0013	0.013	CbGeAlD
Dasatinib—Musculoskeletal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00129	0.00509	CcSEcCtD
Dasatinib—Rash maculo-papular—Colchicine—primary biliary cirrhosis	0.00129	0.00509	CcSEcCtD
Dasatinib—SRC—smooth muscle tissue—primary biliary cirrhosis	0.00127	0.0128	CbGeAlD
Dasatinib—TESK1—liver—primary biliary cirrhosis	0.00122	0.0123	CbGeAlD
Dasatinib—Fluid retention—Chenodeoxycholic acid—primary biliary cirrhosis	0.00121	0.00477	CcSEcCtD
Dasatinib—Fluid retention—Ursodeoxycholic acid—primary biliary cirrhosis	0.00121	0.00477	CcSEcCtD
Dasatinib—STK36—liver—primary biliary cirrhosis	0.0012	0.0121	CbGeAlD
Dasatinib—Oesophagitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00459	CcSEcCtD
Dasatinib—Oesophagitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00459	CcSEcCtD
Dasatinib—LIMK2—liver—primary biliary cirrhosis	0.00116	0.0117	CbGeAlD
Dasatinib—Ecchymosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00115	0.00455	CcSEcCtD
Dasatinib—Neoplasm—Ursodeoxycholic acid—primary biliary cirrhosis	0.00115	0.00455	CcSEcCtD
Dasatinib—Ecchymosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00115	0.00455	CcSEcCtD
Dasatinib—Neoplasm—Chenodeoxycholic acid—primary biliary cirrhosis	0.00115	0.00455	CcSEcCtD
Dasatinib—CSF1R—smooth muscle tissue—primary biliary cirrhosis	0.00114	0.0115	CbGeAlD
Dasatinib—STK35—liver—primary biliary cirrhosis	0.00113	0.0113	CbGeAlD
Dasatinib—CSK—liver—primary biliary cirrhosis	0.00112	0.0113	CbGeAlD
Dasatinib—HCK—liver—primary biliary cirrhosis	0.00111	0.0111	CbGeAlD
Dasatinib—ABL2—liver—primary biliary cirrhosis	0.0011	0.0111	CbGeAlD
Dasatinib—KIT—epithelium—primary biliary cirrhosis	0.00108	0.0108	CbGeAlD
Dasatinib—Photosensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.00105	0.00416	CcSEcCtD
Dasatinib—Photosensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.00105	0.00416	CcSEcCtD
Dasatinib—PDGFRB—epithelium—primary biliary cirrhosis	0.00105	0.0106	CbGeAlD
Dasatinib—RIPK2—liver—primary biliary cirrhosis	0.00104	0.0105	CbGeAlD
Dasatinib—KIT—smooth muscle tissue—primary biliary cirrhosis	0.00104	0.0104	CbGeAlD
Dasatinib—Gastrointestinal haemorrhage—Colchicine—primary biliary cirrhosis	0.00103	0.00406	CcSEcCtD
Dasatinib—Cardiac failure congestive—Chenodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00403	CcSEcCtD
Dasatinib—Cardiac failure congestive—Ursodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00403	CcSEcCtD
Dasatinib—SIK1—liver—primary biliary cirrhosis	0.00102	0.0102	CbGeAlD
Dasatinib—PDGFRB—smooth muscle tissue—primary biliary cirrhosis	0.00101	0.0102	CbGeAlD
Dasatinib—ERBB3—liver—primary biliary cirrhosis	0.000996	0.01	CbGeAlD
Dasatinib—MAP3K2—liver—primary biliary cirrhosis	0.000987	0.00992	CbGeAlD
Dasatinib—Amnesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000985	0.00389	CcSEcCtD
Dasatinib—Amnesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000985	0.00389	CcSEcCtD
Dasatinib—Atrial fibrillation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000977	0.00385	CcSEcCtD
Dasatinib—Atrial fibrillation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000977	0.00385	CcSEcCtD
Dasatinib—Blood creatinine increased—Colchicine—primary biliary cirrhosis	0.000965	0.00381	CcSEcCtD
Dasatinib—Cardiac failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.000948	0.00374	CcSEcCtD
Dasatinib—Cardiac failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.000948	0.00374	CcSEcCtD
Dasatinib—Cerebrovascular accident—Chenodeoxycholic acid—primary biliary cirrhosis	0.000944	0.00372	CcSEcCtD
Dasatinib—Cerebrovascular accident—Ursodeoxycholic acid—primary biliary cirrhosis	0.000944	0.00372	CcSEcCtD
Dasatinib—Aspartate aminotransferase increased—Colchicine—primary biliary cirrhosis	0.000928	0.00366	CcSEcCtD
Dasatinib—MAPK14—liver—primary biliary cirrhosis	0.000928	0.00932	CbGeAlD
Dasatinib—Gastrointestinal haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.000926	0.00365	CcSEcCtD
Dasatinib—Gastrointestinal haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.000926	0.00365	CcSEcCtD
Dasatinib—FGR—liver—primary biliary cirrhosis	0.000924	0.00929	CbGeAlD
Dasatinib—LCK—liver—primary biliary cirrhosis	0.000924	0.00929	CbGeAlD
Dasatinib—Alanine aminotransferase increased—Colchicine—primary biliary cirrhosis	0.000909	0.00358	CcSEcCtD
Dasatinib—Muscular weakness—Colchicine—primary biliary cirrhosis	0.000909	0.00358	CcSEcCtD
Dasatinib—ABL1—smooth muscle tissue—primary biliary cirrhosis	0.000902	0.00907	CbGeAlD
Dasatinib—Face oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000894	0.00352	CcSEcCtD
Dasatinib—Face oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000894	0.00352	CcSEcCtD
Dasatinib—FMO3—liver—primary biliary cirrhosis	0.000892	0.00897	CbGeAlD
Dasatinib—EPHB4—liver—primary biliary cirrhosis	0.000879	0.00884	CbGeAlD
Dasatinib—JAK2—liver—primary biliary cirrhosis	0.000873	0.00878	CbGeAlD
Dasatinib—Blood creatinine increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000867	0.00342	CcSEcCtD
Dasatinib—Blood creatinine increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000867	0.00342	CcSEcCtD
Dasatinib—EPHA2—liver—primary biliary cirrhosis	0.000863	0.00867	CbGeAlD
Dasatinib—FYN—liver—primary biliary cirrhosis	0.000861	0.00866	CbGeAlD
Dasatinib—Pancytopenia—Colchicine—primary biliary cirrhosis	0.000846	0.00333	CcSEcCtD
Dasatinib—MAP3K3—liver—primary biliary cirrhosis	0.000841	0.00846	CbGeAlD
Dasatinib—MAP4K5—liver—primary biliary cirrhosis	0.000841	0.00846	CbGeAlD
Dasatinib—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000836	0.0033	CcSEcCtD
Dasatinib—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000836	0.0033	CcSEcCtD
Dasatinib—Aspartate aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000833	0.00329	CcSEcCtD
Dasatinib—Aspartate aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000833	0.00329	CcSEcCtD
Dasatinib—Neutropenia—Colchicine—primary biliary cirrhosis	0.000833	0.00328	CcSEcCtD
Dasatinib—Gastritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000819	0.00323	CcSEcCtD
Dasatinib—Gastritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000819	0.00323	CcSEcCtD
Dasatinib—Alanine aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000816	0.00322	CcSEcCtD
Dasatinib—Alanine aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000816	0.00322	CcSEcCtD
Dasatinib—Dysphagia—Chenodeoxycholic acid—primary biliary cirrhosis	0.0008	0.00315	CcSEcCtD
Dasatinib—Asthma—Chenodeoxycholic acid—primary biliary cirrhosis	0.0008	0.00315	CcSEcCtD
Dasatinib—Dysphagia—Ursodeoxycholic acid—primary biliary cirrhosis	0.0008	0.00315	CcSEcCtD
Dasatinib—Asthma—Ursodeoxycholic acid—primary biliary cirrhosis	0.0008	0.00315	CcSEcCtD
Dasatinib—Pancreatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000784	0.00309	CcSEcCtD
Dasatinib—Pancreatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000784	0.00309	CcSEcCtD
Dasatinib—Angina pectoris—Chenodeoxycholic acid—primary biliary cirrhosis	0.000779	0.00307	CcSEcCtD
Dasatinib—Angina pectoris—Ursodeoxycholic acid—primary biliary cirrhosis	0.000779	0.00307	CcSEcCtD
Dasatinib—Neuropathy peripheral—Colchicine—primary biliary cirrhosis	0.000778	0.00307	CcSEcCtD
Dasatinib—YES1—liver—primary biliary cirrhosis	0.000777	0.00781	CbGeAlD
Dasatinib—Stomatitis—Colchicine—primary biliary cirrhosis	0.000774	0.00305	CcSEcCtD
Dasatinib—CYP1B1—smooth muscle tissue—primary biliary cirrhosis	0.000764	0.00768	CbGeAlD
Dasatinib—PDGFRA—liver—primary biliary cirrhosis	0.000762	0.00766	CbGeAlD
Dasatinib—Haematuria—Colchicine—primary biliary cirrhosis	0.000757	0.00299	CcSEcCtD
Dasatinib—SRC—liver—primary biliary cirrhosis	0.000748	0.00752	CbGeAlD
Dasatinib—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000743	0.00293	CcSEcCtD
Dasatinib—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000743	0.00293	CcSEcCtD
Dasatinib—Pollakiuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000739	0.00291	CcSEcCtD
Dasatinib—Pollakiuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000739	0.00291	CcSEcCtD
Dasatinib—Photosensitivity reaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.00073	0.00288	CcSEcCtD
Dasatinib—Photosensitivity reaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.00073	0.00288	CcSEcCtD
Dasatinib—Weight increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000728	0.00287	CcSEcCtD
Dasatinib—Weight increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000728	0.00287	CcSEcCtD
Dasatinib—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000724	0.00285	CcSEcCtD
Dasatinib—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000724	0.00285	CcSEcCtD
Dasatinib—Pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000717	0.00283	CcSEcCtD
Dasatinib—Pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000717	0.00283	CcSEcCtD
Dasatinib—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.000713	0.00281	CcSEcCtD
Dasatinib—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000713	0.00281	CcSEcCtD
Dasatinib—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.000713	0.00281	CcSEcCtD
Dasatinib—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000713	0.00281	CcSEcCtD
Dasatinib—Acute coronary syndrome—Ursodeoxycholic acid—primary biliary cirrhosis	0.000703	0.00277	CcSEcCtD
Dasatinib—Acute coronary syndrome—Chenodeoxycholic acid—primary biliary cirrhosis	0.000703	0.00277	CcSEcCtD
Dasatinib—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.000701	0.00277	CcSEcCtD
Dasatinib—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.000701	0.00277	CcSEcCtD
Dasatinib—Myocardial infarction—Chenodeoxycholic acid—primary biliary cirrhosis	0.000699	0.00276	CcSEcCtD
Dasatinib—Myocardial infarction—Ursodeoxycholic acid—primary biliary cirrhosis	0.000699	0.00276	CcSEcCtD
Dasatinib—Conjunctivitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000693	0.00273	CcSEcCtD
Dasatinib—Conjunctivitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000693	0.00273	CcSEcCtD
Dasatinib—MAP2K5—liver—primary biliary cirrhosis	0.000688	0.00691	CbGeAlD
Dasatinib—Haematuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00068	0.00268	CcSEcCtD
Dasatinib—Haematuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00068	0.00268	CcSEcCtD
Dasatinib—Hepatobiliary disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.000675	0.00266	CcSEcCtD
Dasatinib—Hepatobiliary disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.000675	0.00266	CcSEcCtD
Dasatinib—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000673	0.00265	CcSEcCtD
Dasatinib—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000673	0.00265	CcSEcCtD
Dasatinib—CSF1R—liver—primary biliary cirrhosis	0.000671	0.00675	CbGeAlD
Dasatinib—Eye disorder—Colchicine—primary biliary cirrhosis	0.000666	0.00263	CcSEcCtD
Dasatinib—Haemoglobin—Ursodeoxycholic acid—primary biliary cirrhosis	0.000644	0.00254	CcSEcCtD
Dasatinib—Haemoglobin—Chenodeoxycholic acid—primary biliary cirrhosis	0.000644	0.00254	CcSEcCtD
Dasatinib—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.000642	0.00253	CcSEcCtD
Dasatinib—Haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.00064	0.00253	CcSEcCtD
Dasatinib—Haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.00064	0.00253	CcSEcCtD
Dasatinib—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000632	0.00249	CcSEcCtD
Dasatinib—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000632	0.00249	CcSEcCtD
Dasatinib—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.000631	0.00249	CcSEcCtD
Dasatinib—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.000631	0.00249	CcSEcCtD
Dasatinib—Alopecia—Colchicine—primary biliary cirrhosis	0.00063	0.00248	CcSEcCtD
Dasatinib—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000629	0.00248	CcSEcCtD
Dasatinib—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000629	0.00248	CcSEcCtD
Dasatinib—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000628	0.00248	CcSEcCtD
Dasatinib—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000628	0.00248	CcSEcCtD
Dasatinib—Malnutrition—Colchicine—primary biliary cirrhosis	0.00062	0.00245	CcSEcCtD
Dasatinib—Visual impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.000617	0.00243	CcSEcCtD
Dasatinib—Visual impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.000617	0.00243	CcSEcCtD
Dasatinib—KIT—liver—primary biliary cirrhosis	0.000609	0.00613	CbGeAlD
Dasatinib—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000598	0.00236	CcSEcCtD
Dasatinib—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000598	0.00236	CcSEcCtD
Dasatinib—Tinnitus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000597	0.00235	CcSEcCtD
Dasatinib—Tinnitus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000597	0.00235	CcSEcCtD
Dasatinib—Muscle spasms—Colchicine—primary biliary cirrhosis	0.000596	0.00235	CcSEcCtD
Dasatinib—PDGFRB—liver—primary biliary cirrhosis	0.000595	0.00598	CbGeAlD
Dasatinib—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000594	0.00234	CcSEcCtD
Dasatinib—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000594	0.00234	CcSEcCtD
Dasatinib—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.000581	0.00229	CcSEcCtD
Dasatinib—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.000581	0.00229	CcSEcCtD
Dasatinib—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000578	0.00228	CcSEcCtD
Dasatinib—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000578	0.00228	CcSEcCtD
Dasatinib—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000577	0.00228	CcSEcCtD
Dasatinib—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000577	0.00228	CcSEcCtD
Dasatinib—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.000575	0.00227	CcSEcCtD
Dasatinib—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.000575	0.00227	CcSEcCtD
Dasatinib—Anaemia—Colchicine—primary biliary cirrhosis	0.000573	0.00226	CcSEcCtD
Dasatinib—Arrhythmia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000572	0.00226	CcSEcCtD
Dasatinib—Arrhythmia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000572	0.00226	CcSEcCtD
Dasatinib—Alopecia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000566	0.00223	CcSEcCtD
Dasatinib—Alopecia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000566	0.00223	CcSEcCtD
Dasatinib—CYP1A1—epithelium—primary biliary cirrhosis	0.00056	0.00563	CbGeAlD
Dasatinib—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.000557	0.0022	CcSEcCtD
Dasatinib—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.000557	0.0022	CcSEcCtD
Dasatinib—Muscle spasms—Chenodeoxycholic acid—primary biliary cirrhosis	0.000536	0.00211	CcSEcCtD
Dasatinib—Muscle spasms—Ursodeoxycholic acid—primary biliary cirrhosis	0.000536	0.00211	CcSEcCtD
Dasatinib—ABL1—liver—primary biliary cirrhosis	0.000531	0.00533	CbGeAlD
Dasatinib—Myalgia—Colchicine—primary biliary cirrhosis	0.000528	0.00208	CcSEcCtD
Dasatinib—Arthralgia—Colchicine—primary biliary cirrhosis	0.000528	0.00208	CcSEcCtD
Dasatinib—Ill-defined disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000517	0.00204	CcSEcCtD
Dasatinib—Ill-defined disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000517	0.00204	CcSEcCtD
Dasatinib—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000515	0.00203	CcSEcCtD
Dasatinib—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000515	0.00203	CcSEcCtD
Dasatinib—Malaise—Chenodeoxycholic acid—primary biliary cirrhosis	0.000503	0.00198	CcSEcCtD
Dasatinib—Malaise—Ursodeoxycholic acid—primary biliary cirrhosis	0.000503	0.00198	CcSEcCtD
Dasatinib—Vertigo—Ursodeoxycholic acid—primary biliary cirrhosis	0.000501	0.00197	CcSEcCtD
Dasatinib—Vertigo—Chenodeoxycholic acid—primary biliary cirrhosis	0.000501	0.00197	CcSEcCtD
Dasatinib—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.0005	0.00197	CcSEcCtD
Dasatinib—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.0005	0.00197	CcSEcCtD
Dasatinib—Shock—Colchicine—primary biliary cirrhosis	0.000498	0.00196	CcSEcCtD
Dasatinib—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.000497	0.00196	CcSEcCtD
Dasatinib—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.000496	0.00196	CcSEcCtD
Dasatinib—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.000493	0.00194	CcSEcCtD
Dasatinib—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.000493	0.00194	CcSEcCtD
Dasatinib—Skin disorder—Colchicine—primary biliary cirrhosis	0.000492	0.00194	CcSEcCtD
Dasatinib—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00049	0.00193	CcSEcCtD
Dasatinib—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00049	0.00193	CcSEcCtD
Dasatinib—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.000486	0.00192	CcSEcCtD
Dasatinib—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.000486	0.00192	CcSEcCtD
Dasatinib—Convulsion—Ursodeoxycholic acid—primary biliary cirrhosis	0.000483	0.0019	CcSEcCtD
Dasatinib—Convulsion—Chenodeoxycholic acid—primary biliary cirrhosis	0.000483	0.0019	CcSEcCtD
Dasatinib—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000481	0.0019	CcSEcCtD
Dasatinib—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000481	0.0019	CcSEcCtD
Dasatinib—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000475	0.00187	CcSEcCtD
Dasatinib—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000475	0.00187	CcSEcCtD
Dasatinib—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000475	0.00187	CcSEcCtD
Dasatinib—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000475	0.00187	CcSEcCtD
Dasatinib—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000475	0.00187	CcSEcCtD
Dasatinib—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000475	0.00187	CcSEcCtD
Dasatinib—Hypotension—Colchicine—primary biliary cirrhosis	0.000473	0.00187	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000471	0.00186	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000471	0.00186	CcSEcCtD
Dasatinib—Discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000469	0.00185	CcSEcCtD
Dasatinib—Discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000469	0.00185	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.000461	0.00182	CcSEcCtD
Dasatinib—Confusional state—Ursodeoxycholic acid—primary biliary cirrhosis	0.000459	0.00181	CcSEcCtD
Dasatinib—Confusional state—Chenodeoxycholic acid—primary biliary cirrhosis	0.000459	0.00181	CcSEcCtD
Dasatinib—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000455	0.00179	CcSEcCtD
Dasatinib—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000455	0.00179	CcSEcCtD
Dasatinib—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000452	0.00178	CcSEcCtD
Dasatinib—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000452	0.00178	CcSEcCtD
Dasatinib—CYP1B1—liver—primary biliary cirrhosis	0.000449	0.00452	CbGeAlD
Dasatinib—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.000448	0.00177	CcSEcCtD
Dasatinib—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.000448	0.00177	CcSEcCtD
Dasatinib—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000446	0.00176	CcSEcCtD
Dasatinib—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000446	0.00176	CcSEcCtD
Dasatinib—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000445	0.00176	CcSEcCtD
Dasatinib—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000445	0.00176	CcSEcCtD
Dasatinib—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000444	0.00175	CcSEcCtD
Dasatinib—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000444	0.00175	CcSEcCtD
Dasatinib—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000442	0.00174	CcSEcCtD
Dasatinib—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000442	0.00174	CcSEcCtD
Dasatinib—Decreased appetite—Colchicine—primary biliary cirrhosis	0.00044	0.00174	CcSEcCtD
Dasatinib—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00044	0.00173	CcSEcCtD
Dasatinib—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00044	0.00173	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.000437	0.00172	CcSEcCtD
Dasatinib—Fatigue—Colchicine—primary biliary cirrhosis	0.000437	0.00172	CcSEcCtD
Dasatinib—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000434	0.00171	CcSEcCtD
Dasatinib—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000434	0.00171	CcSEcCtD
Dasatinib—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000425	0.00168	CcSEcCtD
Dasatinib—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000425	0.00168	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000414	0.00163	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000414	0.00163	CcSEcCtD
Dasatinib—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.000414	0.00163	CcSEcCtD
Dasatinib—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000411	0.00162	CcSEcCtD
Dasatinib—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000411	0.00162	CcSEcCtD
Dasatinib—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000406	0.0016	CcSEcCtD
Dasatinib—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000406	0.0016	CcSEcCtD
Dasatinib—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.000404	0.00159	CcSEcCtD
Dasatinib—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.000404	0.00159	CcSEcCtD
Dasatinib—Urticaria—Colchicine—primary biliary cirrhosis	0.000402	0.00159	CcSEcCtD
Dasatinib—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.0004	0.00158	CcSEcCtD
Dasatinib—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.0004	0.00158	CcSEcCtD
Dasatinib—Abdominal pain—Colchicine—primary biliary cirrhosis	0.0004	0.00158	CcSEcCtD
Dasatinib—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.000395	0.00156	CcSEcCtD
Dasatinib—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.000395	0.00156	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000393	0.00155	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000393	0.00155	CcSEcCtD
Dasatinib—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000392	0.00155	CcSEcCtD
Dasatinib—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000392	0.00155	CcSEcCtD
Dasatinib—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000389	0.00153	CcSEcCtD
Dasatinib—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000389	0.00153	CcSEcCtD
Dasatinib—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000389	0.00153	CcSEcCtD
Dasatinib—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000389	0.00153	CcSEcCtD
Dasatinib—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.000375	0.00148	CcSEcCtD
Dasatinib—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.000375	0.00148	CcSEcCtD
Dasatinib—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.000373	0.00147	CcSEcCtD
Dasatinib—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000372	0.00147	CcSEcCtD
Dasatinib—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000372	0.00147	CcSEcCtD
Dasatinib—Asthenia—Colchicine—primary biliary cirrhosis	0.000363	0.00143	CcSEcCtD
Dasatinib—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000361	0.00143	CcSEcCtD
Dasatinib—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000361	0.00143	CcSEcCtD
Dasatinib—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00036	0.00142	CcSEcCtD
Dasatinib—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00036	0.00142	CcSEcCtD
Dasatinib—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00036	0.00142	CcSEcCtD
Dasatinib—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00036	0.00142	CcSEcCtD
Dasatinib—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000346	0.00137	CcSEcCtD
Dasatinib—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.000335	0.00132	CcSEcCtD
Dasatinib—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.000335	0.00132	CcSEcCtD
Dasatinib—ABCG2—liver—primary biliary cirrhosis	0.000335	0.00336	CbGeAlD
Dasatinib—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000326	0.00129	CcSEcCtD
Dasatinib—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000326	0.00129	CcSEcCtD
Dasatinib—CYP1A2—liver—primary biliary cirrhosis	0.000322	0.00324	CbGeAlD
Dasatinib—Vomiting—Colchicine—primary biliary cirrhosis	0.000322	0.00127	CcSEcCtD
Dasatinib—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000322	0.00127	CcSEcCtD
Dasatinib—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000322	0.00127	CcSEcCtD
Dasatinib—Rash—Colchicine—primary biliary cirrhosis	0.000319	0.00126	CcSEcCtD
Dasatinib—Dermatitis—Colchicine—primary biliary cirrhosis	0.000319	0.00126	CcSEcCtD
Dasatinib—CYP1A1—liver—primary biliary cirrhosis	0.000318	0.00319	CbGeAlD
Dasatinib—Headache—Colchicine—primary biliary cirrhosis	0.000317	0.00125	CcSEcCtD
Dasatinib—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000311	0.00123	CcSEcCtD
Dasatinib—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000311	0.00123	CcSEcCtD
Dasatinib—CYP3A5—liver—primary biliary cirrhosis	0.000311	0.00312	CbGeAlD
Dasatinib—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000301	0.00119	CcSEcCtD
Dasatinib—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000301	0.00119	CcSEcCtD
Dasatinib—Nausea—Colchicine—primary biliary cirrhosis	0.000301	0.00119	CcSEcCtD
Dasatinib—ABCB1—epithelium—primary biliary cirrhosis	0.000291	0.00293	CbGeAlD
Dasatinib—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000289	0.00114	CcSEcCtD
Dasatinib—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000289	0.00114	CcSEcCtD
Dasatinib—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000287	0.00113	CcSEcCtD
Dasatinib—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000287	0.00113	CcSEcCtD
Dasatinib—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000287	0.00113	CcSEcCtD
Dasatinib—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000287	0.00113	CcSEcCtD
Dasatinib—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.000285	0.00112	CcSEcCtD
Dasatinib—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.000285	0.00112	CcSEcCtD
Dasatinib—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00027	0.00107	CcSEcCtD
Dasatinib—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00027	0.00107	CcSEcCtD
Dasatinib—CYP3A4—liver—primary biliary cirrhosis	0.000233	0.00234	CbGeAlD
Dasatinib—ABCB1—liver—primary biliary cirrhosis	0.000165	0.00166	CbGeAlD
Dasatinib—PDGFRB—Adaptive Immune System—NFKB1—primary biliary cirrhosis	7.9e-06	2.99e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—MMP3—primary biliary cirrhosis	7.9e-06	2.99e-05	CbGpPWpGaD
Dasatinib—KIT—Disease—CD80—primary biliary cirrhosis	7.89e-06	2.98e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—CD40LG—primary biliary cirrhosis	7.86e-06	2.97e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—GGT1—primary biliary cirrhosis	7.84e-06	2.97e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—GOT1—primary biliary cirrhosis	7.84e-06	2.97e-05	CbGpPWpGaD
Dasatinib—BLK—Immune System—NFKB1—primary biliary cirrhosis	7.82e-06	2.96e-05	CbGpPWpGaD
Dasatinib—FGR—Immune System—NFKB1—primary biliary cirrhosis	7.8e-06	2.95e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—GOT1—primary biliary cirrhosis	7.78e-06	2.94e-05	CbGpPWpGaD
Dasatinib—LYN—Adaptive Immune System—NFKB1—primary biliary cirrhosis	7.74e-06	2.93e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—NOS2—primary biliary cirrhosis	7.7e-06	2.91e-05	CbGpPWpGaD
Dasatinib—MAPK14—Innate Immune System—NFKB1—primary biliary cirrhosis	7.64e-06	2.89e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—HIF1A—primary biliary cirrhosis	7.62e-06	2.88e-05	CbGpPWpGaD
Dasatinib—FYN—Adaptive Immune System—NFKB1—primary biliary cirrhosis	7.62e-06	2.88e-05	CbGpPWpGaD
Dasatinib—JAK2—Innate Immune System—NFKB1—primary biliary cirrhosis	7.54e-06	2.85e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	7.51e-06	2.84e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—DLAT—primary biliary cirrhosis	7.51e-06	2.84e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ABCB4—primary biliary cirrhosis	7.51e-06	2.84e-05	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—TYK2—primary biliary cirrhosis	7.5e-06	2.84e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—NUP210—primary biliary cirrhosis	7.49e-06	2.83e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—MMP3—primary biliary cirrhosis	7.48e-06	2.83e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—CD80—primary biliary cirrhosis	7.47e-06	2.82e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—CCL5—primary biliary cirrhosis	7.45e-06	2.82e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CXCL10—primary biliary cirrhosis	7.38e-06	2.79e-05	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—MMP9—primary biliary cirrhosis	7.35e-06	2.78e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—HIF1A—primary biliary cirrhosis	7.35e-06	2.78e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—CD80—primary biliary cirrhosis	7.31e-06	2.77e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—CD80—primary biliary cirrhosis	7.29e-06	2.76e-05	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—NFKB1—primary biliary cirrhosis	7.27e-06	2.75e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CXCL10—primary biliary cirrhosis	7.23e-06	2.74e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	7.22e-06	2.73e-05	CbGpPWpGaD
Dasatinib—KIT—Immune System—TYK2—primary biliary cirrhosis	7.21e-06	2.73e-05	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—NFKB1—primary biliary cirrhosis	7.17e-06	2.71e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—CD80—primary biliary cirrhosis	7.13e-06	2.7e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—GGT1—primary biliary cirrhosis	7.13e-06	2.7e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—GOT1—primary biliary cirrhosis	7.13e-06	2.7e-05	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—MMP9—primary biliary cirrhosis	7.12e-06	2.69e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CXCL10—primary biliary cirrhosis	7.12e-06	2.69e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—CD80—primary biliary cirrhosis	7.1e-06	2.69e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—NUP210—primary biliary cirrhosis	7.08e-06	2.68e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—CCL5—primary biliary cirrhosis	7.06e-06	2.67e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—CD80—primary biliary cirrhosis	7.05e-06	2.67e-05	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—NFKB1—primary biliary cirrhosis	7.04e-06	2.66e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—CD80—primary biliary cirrhosis	7.02e-06	2.66e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—HIF1A—primary biliary cirrhosis	7.01e-06	2.65e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—HIF1A—primary biliary cirrhosis	6.98e-06	2.64e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—AGT—primary biliary cirrhosis	6.98e-06	2.64e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—PPARGC1A—primary biliary cirrhosis	6.98e-06	2.64e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—ABCG2—primary biliary cirrhosis	6.96e-06	2.63e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—CD40LG—primary biliary cirrhosis	6.96e-06	2.63e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—NOS2—primary biliary cirrhosis	6.93e-06	2.62e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	6.91e-06	2.62e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	6.91e-06	2.62e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CXCL10—primary biliary cirrhosis	6.85e-06	2.59e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	6.84e-06	2.59e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—TYK2—primary biliary cirrhosis	6.83e-06	2.58e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CXCL10—primary biliary cirrhosis	6.77e-06	2.56e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—CD80—primary biliary cirrhosis	6.76e-06	2.56e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—TYK2—primary biliary cirrhosis	6.75e-06	2.55e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—MMP3—primary biliary cirrhosis	6.73e-06	2.55e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—CD80—primary biliary cirrhosis	6.73e-06	2.54e-05	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—MMP9—primary biliary cirrhosis	6.69e-06	2.53e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—NOS2—primary biliary cirrhosis	6.68e-06	2.53e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—CD80—primary biliary cirrhosis	6.68e-06	2.53e-05	CbGpPWpGaD
Dasatinib—KIT—Disease—TYK2—primary biliary cirrhosis	6.66e-06	2.52e-05	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—NFKB1—primary biliary cirrhosis	6.62e-06	2.5e-05	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—NFKB1—primary biliary cirrhosis	6.6e-06	2.5e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—MMP3—primary biliary cirrhosis	6.59e-06	2.49e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—ABCG2—primary biliary cirrhosis	6.58e-06	2.49e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—MMP3—primary biliary cirrhosis	6.49e-06	2.46e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—CD80—primary biliary cirrhosis	6.48e-06	2.45e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CCL5—primary biliary cirrhosis	6.36e-06	2.4e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—NOS2—primary biliary cirrhosis	6.35e-06	2.4e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—PPARGC1A—primary biliary cirrhosis	6.35e-06	2.4e-05	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—NFKB1—primary biliary cirrhosis	6.34e-06	2.4e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—TYK2—primary biliary cirrhosis	6.3e-06	2.38e-05	CbGpPWpGaD
Dasatinib—YES1—Immune System—NFKB1—primary biliary cirrhosis	6.29e-06	2.38e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—HIF1A—primary biliary cirrhosis	6.26e-06	2.37e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—MMP3—primary biliary cirrhosis	6.25e-06	2.36e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—AGT—primary biliary cirrhosis	6.23e-06	2.36e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CCL5—primary biliary cirrhosis	6.22e-06	2.35e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—CD80—primary biliary cirrhosis	6.18e-06	2.34e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—MMP3—primary biliary cirrhosis	6.17e-06	2.33e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—TYK2—primary biliary cirrhosis	6.17e-06	2.33e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—TYK2—primary biliary cirrhosis	6.17e-06	2.33e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—CD80—primary biliary cirrhosis	6.16e-06	2.33e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	6.16e-06	2.33e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	6.16e-06	2.33e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	6.15e-06	2.33e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—TYK2—primary biliary cirrhosis	6.15e-06	2.33e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CCL5—primary biliary cirrhosis	6.13e-06	2.32e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—HIF1A—primary biliary cirrhosis	6.12e-06	2.31e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	6.03e-06	2.28e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—TYK2—primary biliary cirrhosis	6.02e-06	2.28e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—TYK2—primary biliary cirrhosis	5.99e-06	2.27e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—CTGF—primary biliary cirrhosis	5.97e-06	2.26e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—TYK2—primary biliary cirrhosis	5.95e-06	2.25e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	5.94e-06	2.25e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—TYK2—primary biliary cirrhosis	5.93e-06	2.24e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CXCL10—primary biliary cirrhosis	5.93e-06	2.24e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—HIF1A—primary biliary cirrhosis	5.92e-06	2.24e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—GOT2—primary biliary cirrhosis	5.92e-06	2.24e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—AGT—primary biliary cirrhosis	5.9e-06	2.23e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CCL5—primary biliary cirrhosis	5.9e-06	2.23e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—CD80—primary biliary cirrhosis	5.85e-06	2.21e-05	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—NFKB1—primary biliary cirrhosis	5.85e-06	2.21e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CCL5—primary biliary cirrhosis	5.82e-06	2.2e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	5.79e-06	2.19e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	5.79e-06	2.19e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	5.77e-06	2.18e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	5.72e-06	2.16e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—TYK2—primary biliary cirrhosis	5.71e-06	2.16e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—TYK2—primary biliary cirrhosis	5.68e-06	2.15e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—NUP210—primary biliary cirrhosis	5.65e-06	2.14e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	5.64e-06	2.14e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—CTGF—primary biliary cirrhosis	5.64e-06	2.14e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—TYK2—primary biliary cirrhosis	5.64e-06	2.13e-05	CbGpPWpGaD
Dasatinib—KIT—Immune System—NFKB1—primary biliary cirrhosis	5.62e-06	2.13e-05	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—NFKB1—primary biliary cirrhosis	5.61e-06	2.12e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—GOT2—primary biliary cirrhosis	5.59e-06	2.12e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—NOS2—primary biliary cirrhosis	5.56e-06	2.1e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—CD80—primary biliary cirrhosis	5.52e-06	2.09e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—TYK2—primary biliary cirrhosis	5.47e-06	2.07e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—AGT—primary biliary cirrhosis	5.43e-06	2.06e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—HIF1A—primary biliary cirrhosis	5.41e-06	2.05e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MMP3—primary biliary cirrhosis	5.4e-06	2.04e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—CD80—primary biliary cirrhosis	5.4e-06	2.04e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—HIF1A—primary biliary cirrhosis	5.34e-06	2.02e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—NFKB1—primary biliary cirrhosis	5.32e-06	2.01e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—AGT—primary biliary cirrhosis	5.32e-06	2.01e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—MMP9—primary biliary cirrhosis	5.31e-06	2.01e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—NFKB1—primary biliary cirrhosis	5.26e-06	1.99e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—ABCG2—primary biliary cirrhosis	5.25e-06	1.99e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CXCL10—primary biliary cirrhosis	5.25e-06	1.98e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—CD80—primary biliary cirrhosis	5.23e-06	1.98e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—HIF1A—primary biliary cirrhosis	5.23e-06	1.98e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—TYK2—primary biliary cirrhosis	5.22e-06	1.98e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—AGT—primary biliary cirrhosis	5.21e-06	1.97e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—TYK2—primary biliary cirrhosis	5.2e-06	1.97e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—CD80—primary biliary cirrhosis	5.18e-06	1.96e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—HIF1A—primary biliary cirrhosis	5.14e-06	1.95e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—AGT—primary biliary cirrhosis	5.13e-06	1.94e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—GGT1—primary biliary cirrhosis	5.11e-06	1.93e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—GOT1—primary biliary cirrhosis	5.11e-06	1.93e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CCL5—primary biliary cirrhosis	5.1e-06	1.93e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—HIF1A—primary biliary cirrhosis	4.95e-06	1.87e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—AGT—primary biliary cirrhosis	4.94e-06	1.87e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	4.94e-06	1.87e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—TYK2—primary biliary cirrhosis	4.94e-06	1.87e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—AGT—primary biliary cirrhosis	4.94e-06	1.87e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—NOS2—primary biliary cirrhosis	4.93e-06	1.86e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—HIF1A—primary biliary cirrhosis	4.89e-06	1.85e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—AGT—primary biliary cirrhosis	4.87e-06	1.84e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—MMP9—primary biliary cirrhosis	4.86e-06	1.84e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—GGT1—primary biliary cirrhosis	4.83e-06	1.83e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—GOT1—primary biliary cirrhosis	4.83e-06	1.83e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—NFKB1—primary biliary cirrhosis	4.81e-06	1.82e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—NFKB1—primary biliary cirrhosis	4.79e-06	1.81e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	4.79e-06	1.81e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MMP3—primary biliary cirrhosis	4.78e-06	1.81e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—CD80—primary biliary cirrhosis	4.78e-06	1.81e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CD80—primary biliary cirrhosis	4.71e-06	1.78e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—NFKB1—primary biliary cirrhosis	4.69e-06	1.78e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—MMP9—primary biliary cirrhosis	4.68e-06	1.77e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—NFKB1—primary biliary cirrhosis	4.67e-06	1.77e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—TYK2—primary biliary cirrhosis	4.66e-06	1.76e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—NFKB1—primary biliary cirrhosis	4.63e-06	1.75e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—NFKB1—primary biliary cirrhosis	4.62e-06	1.75e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CD80—primary biliary cirrhosis	4.61e-06	1.74e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—TYK2—primary biliary cirrhosis	4.56e-06	1.72e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PPARGC1A—primary biliary cirrhosis	4.55e-06	1.72e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CD80—primary biliary cirrhosis	4.54e-06	1.72e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CCL5—primary biliary cirrhosis	4.52e-06	1.71e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—NUP210—primary biliary cirrhosis	4.51e-06	1.71e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CTGF—primary biliary cirrhosis	4.51e-06	1.71e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GOT2—primary biliary cirrhosis	4.47e-06	1.69e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—NFKB1—primary biliary cirrhosis	4.45e-06	1.68e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—TYK2—primary biliary cirrhosis	4.41e-06	1.67e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—NFKB1—primary biliary cirrhosis	4.39e-06	1.66e-05	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	4.38e-06	1.66e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	4.38e-06	1.66e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CD80—primary biliary cirrhosis	4.37e-06	1.65e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—TYK2—primary biliary cirrhosis	4.37e-06	1.65e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CD80—primary biliary cirrhosis	4.32e-06	1.63e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PPARGC1A—primary biliary cirrhosis	4.3e-06	1.63e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—HIF1A—primary biliary cirrhosis	4.28e-06	1.62e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—AGT—primary biliary cirrhosis	4.27e-06	1.61e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ABCG2—primary biliary cirrhosis	4.19e-06	1.59e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—ALB—primary biliary cirrhosis	4.17e-06	1.58e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—MMP9—primary biliary cirrhosis	4.11e-06	1.56e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—NFKB1—primary biliary cirrhosis	4.07e-06	1.54e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—TYK2—primary biliary cirrhosis	4.03e-06	1.53e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—TYK2—primary biliary cirrhosis	3.98e-06	1.5e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TYK2—primary biliary cirrhosis	3.89e-06	1.47e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GGT1—primary biliary cirrhosis	3.86e-06	1.46e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GOT1—primary biliary cirrhosis	3.86e-06	1.46e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—NFKB1—primary biliary cirrhosis	3.85e-06	1.45e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TYK2—primary biliary cirrhosis	3.83e-06	1.45e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—ALB—primary biliary cirrhosis	3.79e-06	1.44e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—HIF1A—primary biliary cirrhosis	3.79e-06	1.43e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CD80—primary biliary cirrhosis	3.78e-06	1.43e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—AGT—primary biliary cirrhosis	3.78e-06	1.43e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TYK2—primary biliary cirrhosis	3.69e-06	1.4e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	3.68e-06	1.39e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—MMP9—primary biliary cirrhosis	3.67e-06	1.39e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TYK2—primary biliary cirrhosis	3.64e-06	1.38e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.63e-06	1.37e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CTGF—primary biliary cirrhosis	3.6e-06	1.36e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GOT2—primary biliary cirrhosis	3.57e-06	1.35e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—AGT—primary biliary cirrhosis	3.54e-06	1.34e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	3.48e-06	1.32e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—MMP9—primary biliary cirrhosis	3.48e-06	1.32e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.44e-06	1.3e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PPARGC1A—primary biliary cirrhosis	3.43e-06	1.3e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—NFKB1—primary biliary cirrhosis	3.4e-06	1.29e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CD80—primary biliary cirrhosis	3.35e-06	1.27e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—AGT—primary biliary cirrhosis	3.35e-06	1.27e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	3.24e-06	1.22e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TYK2—primary biliary cirrhosis	3.19e-06	1.21e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—MMP9—primary biliary cirrhosis	3.13e-06	1.18e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.1e-06	1.17e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GOT1—primary biliary cirrhosis	3.08e-06	1.16e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GGT1—primary biliary cirrhosis	3.08e-06	1.16e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—MMP9—primary biliary cirrhosis	3.07e-06	1.16e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.03e-06	1.15e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—MMP9—primary biliary cirrhosis	3.02e-06	1.14e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.99e-06	1.13e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—MMP9—primary biliary cirrhosis	2.91e-06	1.1e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.88e-06	1.09e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—MMP9—primary biliary cirrhosis	2.87e-06	1.09e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.84e-06	1.07e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TYK2—primary biliary cirrhosis	2.82e-06	1.07e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	2.78e-06	1.05e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	2.75e-06	1.04e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PPARGC1A—primary biliary cirrhosis	2.74e-06	1.04e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—ALB—primary biliary cirrhosis	2.72e-06	1.03e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—AGT—primary biliary cirrhosis	2.67e-06	1.01e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—ALB—primary biliary cirrhosis	2.57e-06	9.72e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MMP9—primary biliary cirrhosis	2.51e-06	9.51e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.49e-06	9.41e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	2.38e-06	8.99e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	2.38e-06	8.99e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MMP9—primary biliary cirrhosis	2.22e-06	8.42e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.2e-06	8.33e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—AGT—primary biliary cirrhosis	2.13e-06	8.07e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	2.11e-06	8e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—ALB—primary biliary cirrhosis	2.05e-06	7.76e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	1.65e-06	6.23e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ALB—primary biliary cirrhosis	1.64e-06	6.19e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	1.26e-06	4.78e-06	CbGpPWpGaD
